Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORC
2751
Orchid Island Capital
ORC
$1.32B
| $1.56M | ﹤0.01% |
63,862
+15,656
| +32% | +$394K |
|
2752
REX American Resources
REX
$1.44B
| $1.56M | ﹤0.01% |
117,078
-100,950
| -46% | -$1.36M |
|
2753
ZipRecruiter
ZIP
$388M
| $1.56M | ﹤0.01% |
+56,362
| New | +$1.46M |
|
2754
OneWater Marine
ONEW
$203M
| $1.55M | ﹤0.01% |
38,586
+1,132
| +3% | +$47.5K |
|
2755
PAVmed
PAVM
$33.9M
| $1.54M | ﹤0.01% |
402
-1
| -0.2% | -$3.15K |
|
2756
Vuzix
VUZI
$220M
| $1.53M | ﹤0.01% |
146,331
+773
| +0.5% | +$10.3K |
|
|
SCU
2757
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.53M | ﹤0.01% |
54,727
+1,352
| +3% | +$35.1K |
|
|
PSTX
2758
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.52M | ﹤0.01% |
208,935
+80,870
| +63% | +$694K |
|
2759
Dream Finders Homes
DFH
$1.35B
| $1.52M | ﹤0.01% |
87,846
+39,290
| +81% | +$818K |
|
|
CATC
2760
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.52M | ﹤0.01% |
17,226
-11
| -0.1% | -$926 |
|
|
TBCH
2761
Turtle Beach Corp
TBCH
$230M
| $1.5M | ﹤0.01% |
54,043
-19,548
| -27% | -$570K |
|
|
BRG
2762
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $1.5M | ﹤0.01% |
117,945
-33,095
| -22% | -$383K |
|
|
CYXT
2763
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $1.49M | ﹤0.01% |
+160,890
| New | +$1.5M |
|
2764
Harvard Bioscience
HBIO
$30.4M
| $1.47M | ﹤0.01% |
20,987
+321
| +2% | +$25.5K |
|
|
ZY
2765
DELISTED
Zymergen Inc. Common Stock
ZY
| $1.45M | ﹤0.01% |
110,181
-6,109
| -5% | -$130K |
|
|
CTT
2766
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $1.45M | ﹤0.01% |
122,306
+398
| +0.3% | +$4.64K |
|
2767
RCI Hospitality Holdings
RICK
$230M
| $1.43M | ﹤0.01% |
20,880
+37
| +0.2% | +$2.42K |
|
|
SKYT
2768
DELISTED
SkyWater Technology
SKYT
| $1.42M | ﹤0.01% |
51,993
+1,403
| +3% | +$36.5K |
|
2769
Oramed Pharmaceuticals
ORMP
$182M
| $1.41M | ﹤0.01% |
64,251
+7,609
| +13% | +$130K |
|
2770
MINISO
MNSO
$3.53B
| $1.4M | ﹤0.01% |
92,009
+1,950
| +2% | +$29.8K |
|
2771
Vor Biopharma
VOR
$1.38B
| $1.4M | ﹤0.01% |
4,473
+1,021
| +30% | +$304K |
|
2772
Edgewise Therapeutics
EWTX
$4.69B
| $1.4M | ﹤0.01% |
84,110
+3,036
| +4% | +$54.9K |
|
|
MILE
2773
DELISTED
Metromile, Inc. Common Stock
MILE
| $1.4M | ﹤0.01% |
393,136
-23,166
| -6% | -$131K |
|
2774
ARS Pharmaceuticals
SPRY
$606M
| $1.39M | ﹤0.01% |
139,105
+53,301
| +62% | +$1.31M |
|
|
ALBO
2775
DELISTED
Albireo Pharma Inc
ALBO
| $1.39M | ﹤0.01% |
44,414
+1,910
| +4% | +$59.1K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.